France Pet Veterinary Diets - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The france pet veterinary diets market size is projected to increase from USD 499.1 million in 2025 to USD 522.2 million in 2026 and reach USD 653.1 million by 2031, growing at a compound annual growth rate (CAGR) of 4.58% over 2026-2031. This report is Segmented by Sub Product (Diabetes, Renal, Urinary Tract Disease, Digestive Sensitivity, and More), by Pets (Cats, Dogs, and More), and by Distribution Channel (Convenience Stores, Online Channel, and More). Forecasts are Provided in Value (USD) and Volume (Metric Tons).

France Pet Veterinary Diets Market Trends and Insights

High Veterinary Visit Frequency for Chronic Pet Conditions in France

The France pet veterinary diets market benefits from a care pathway in which many chronic conditions are identified during regular veterinary visits rather than through emergency interventions. Therapeutic diets are typically included in the treatment plan after a clinician explains the condition, the feeding protocol, and the anticipated duration of use. France was home to approximately 16.6 million cats and 9.9 million dogs in 2024, providing a large companion animal population that is progressively aging and contributing to a higher prevalence of renal, urinary, digestive, and weight-related conditions requiring long-term nutritional management. Cats are particularly significant in this pattern, as chronic kidney disease and urinary disorders often require sustained dietary intervention, supporting stable demand in the France pet veterinary diets market. Regions with higher veterinary density can convert diagnoses into diet initiation more quickly than regions with limited access. As preventive screening becomes more common in senior pet care, earlier disease detection is anticipated to increase the adoption of therapeutic diets, benefiting the France pet veterinary diets market.

Strong Preference for Veterinarian-Recommended Nutrition in France

The France pet veterinary diets market remains closely tied to veterinary recommendations, as pet owners continue to rely on veterinarians as the primary source of guidance for therapeutic nutrition. This gives companies that invest in veterinary education, clinical communication, and prescription-channel support a structural competitive advantage. As a result, veterinary clinics play a central role in product selection, refill guidance, and long-term treatment compliance. This high level of professional trust helps the France pet veterinary diets market remain more resilient than conventional premium pet food categories when therapeutic nutrition is clinically indicated. The French Agency for Food, Environmental and Occupational Health and Safety (ANSES) supports the scientific evaluation and regulatory oversight of animal feed safety and nutrition within the broader European Union regulatory framework. This contributes to veterinarian confidence in the clinically formulated therapeutic diets market.

High Price Premium Versus Standard Pet Food in France

The relatively high cost of prescription veterinary diets is a key restraint in the France pet veterinary diets market. Therapeutic formulations are typically priced higher than standard pet food and are often required for long-term management of chronic conditions. While pet owners generally adopt veterinary diets following a clinical diagnosis, maintaining long-term adherence can be challenging due to the recurring financial commitment. This is particularly relevant for households that bear veterinary and nutritional expenses out of pocket without pet insurance support. In addition, prescription diets increasingly compete with premium non-prescription pet foods marketed for general health and wellness, which are not clinically formulated to manage specific medical conditions. As a result, cost considerations and the availability of lower-priced alternatives can reduce long-term compliance with prescribed nutritional regimens, limiting sustained demand for veterinary diets in France.

Other drivers and restraints analyzed in the detailed report include:

• Rising Demand for Prescription Diets for Obesity and Digestive Sensitivities
• Wider Adoption of Preventive Pet Health Management by French Pet Owners
• Fragmented Consumer Understanding of Clinical Diet Benefits

Segment Analysis

Renal accounted for 22% of France pet veterinary diets market share within the sub product segment in 2025, making it the largest category. This position reflects the long treatment duration associated with kidney disease and the strong clinical reliance on nutrition in disease management. Virbac launched Vikaly in September 2025 as a medicated feed for cats that combines renal kibble with benazepril and requires a veterinary prescription. That move shows that renal nutrition is no longer competing only on base formulation, but also on treatment simplicity and owner adherence. It also raises the barrier to entry, as products in this niche must meet both nutritional and therapeutic expectations.

Obesity diets are the fastest-growing sub-product with a 6.8% CAGR in 2026-2031, which broadens the France pet veterinary diets market beyond traditional renal and urinary cases. Weight-management diets are gaining traction because excess body weight is being handled more like a persistent medical condition than a temporary lifestyle issue. Digestive sensitivity diets also benefit from multi-condition cases, especially in older pets that need gastrointestinal support alongside another clinical need. Diabetes, urinary tract disease, derma diets, oral care diets, and other veterinary diets keep demand diversified across specialist use cases. As more products are tailored to overlapping conditions, the France pet veterinary diets industry is moving from single-issue formulas toward more flexible clinical nutrition.

Complete Report Scope:

• By Sub Product
  • Diabetes
  • Renal
  • Urinary Tract Disease
  • Digestive Sensitivity
  • Oral Care Diets
  • Derma Diets
  • Obesity Diets
  • Other Veterinary Diets
• By Pets
  • Cats
  • Dogs
  • Other Pets
• By Distribution Channel
  • Convenience Stores
  • Online Channel
  • Specialty Stores
  • Supermarkets and Hypermarkets
  • Other Distribution Channels

List of Companies Covered in this Report:

• Mars, Incorporated
• Nestlé S.A.
• Colgate-Palmolive Company
• Virbac S.A.
• Dechra Pharmaceuticals PLC
• Vetoquinol S.A.
• CEVA Santé Animale S.A.S.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Affinity Petcare, S.A.
• Pro-Nutrition Flatazor
• General Mills, Inc.
• Josera Petfood GmbH and Co. KG
• Farmina Pet Foods S.r.l.
• VetPlus Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support